Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 1997 Mar;47(416):150–155.

Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care.

D M Sharp 1, K G Power 1, R J Simpson 1, V Swanson 1, J A Anstee 1
PMCID: PMC1312921  PMID: 9167318

Abstract

BACKGROUND: Panic disorder, with and without agoraphobia, is a prevalent condition which presents primarily in general practice. Previous clinical outcome studies have been conducted mainly in specialist university departments or hospital settings, and have tended to employ complex rating scales that are not well suited for use as outcome measures in primary care. AIM: To evaluate the outcome, in a primary care setting, of fluvoxamine versus cognitive behaviour therapy, each used alone and in combination in a double-blind placebo-controlled framework, balanced for therapist contact. METHOD: A total of 149 patients satisfying DSMIII-R criteria for panic disorder were randomly allocated to receive one of the following: fluvoxamine, placebo, fluvoxamine plus cognitive behaviour therapy, placebo plus cognitive behaviour therapy, and cognitive behaviour therapy alone. These five treatment groups represent the minimum number acceptable for such a comparison to be made. All patients received an identical schedule of contact over 13 weeks. Measures of symptom severity, general health and social disruption were taken at entry point and end point; measures of change in symptoms were taken at end point only. Outcome was reported in terms of brief global ratings of severity of illness and change in symptoms, and of ratings of general health and social disruption that are suitable for use in general practice. RESULTS: All active treatment groups showed statistically significant advantages over placebo over a range of outcome ratings. The groups employing cognitive behaviour therapy showed the most robust and consistent response. CONCLUSION: The brief global measures reported here proved adequate to the task of assessing treatment outcome. Results indicate that treatments including cognitive behaviour therapy can be effective in the treatment of panic disorder and agoraphobia in primary care.

Full Text

The Full Text of this article is available as a PDF (55.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashcroft G. W., Beaumont G., Bonn J., Brandon S., Briggs A., Clark D., Davison K., Gelder M. G., Goldberg D., Herrington R. Consensus statement: panic disorder. Br J Psychiatry. 1987 Apr;150:557–558. doi: 10.1192/bjp.150.4.557. [DOI] [PubMed] [Google Scholar]
  2. Black D. W., Wesner R., Bowers W., Gabel J. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry. 1993 Jan;50(1):44–50. doi: 10.1001/archpsyc.1993.01820130046008. [DOI] [PubMed] [Google Scholar]
  3. Chambless D. L., Gillis M. M. Cognitive therapy of anxiety disorders. J Consult Clin Psychol. 1993 Apr;61(2):248–260. doi: 10.1037//0022-006x.61.2.248. [DOI] [PubMed] [Google Scholar]
  4. Clark D. M., Salkovskis P. M., Hackmann A., Middleton H., Anastasiades P., Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry. 1994 Jun;164(6):759–769. doi: 10.1192/bjp.164.6.759. [DOI] [PubMed] [Google Scholar]
  5. HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. doi: 10.1111/j.2044-8341.1959.tb00467.x. [DOI] [PubMed] [Google Scholar]
  6. Marks I. M., Mathews A. M. Brief standard self-rating for phobic patients. Behav Res Ther. 1979;17(3):263–267. doi: 10.1016/0005-7967(79)90041-x. [DOI] [PubMed] [Google Scholar]
  7. Marks I. M., Swinson R. P., Başoğlu M., Kuch K., Noshirvani H., O'Sullivan G., Lelliott P. T., Kirby M., McNamee G., Sengun S. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. Br J Psychiatry. 1993 Jun;162:776–787. doi: 10.1192/bjp.162.6.776. [DOI] [PubMed] [Google Scholar]
  8. Michelson L., Marchione K., Greenwald M., Glanz L., Testa S., Marchione N. Panic disorder: cognitive-behavioral treatment. Behav Res Ther. 1990;28(2):141–151. doi: 10.1016/0005-7967(90)90026-f. [DOI] [PubMed] [Google Scholar]
  9. Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979 Apr;134:382–389. doi: 10.1192/bjp.134.4.382. [DOI] [PubMed] [Google Scholar]
  10. Ost L. G., Westling B. E., Hellström K. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia. Behav Res Ther. 1993 May;31(4):383–394. doi: 10.1016/0005-7967(93)90095-c. [DOI] [PubMed] [Google Scholar]
  11. Power K. G., Simpson R. J., Swanson V., Wallace L. A. Controlled comparison of pharmacological and psychological treatment of generalized anxiety disorder in primary care. Br J Gen Pract. 1990 Jul;40(336):289–294. [PMC free article] [PubMed] [Google Scholar]
  12. Shear M. K., Ball G., Fitzpatrick M., Josephson S., Klosko J., Frances A. Cognitive-behavioral therapy for panic: an open study. J Nerv Ment Dis. 1991 Aug;179(8):468–472. doi: 10.1097/00005053-199108000-00003. [DOI] [PubMed] [Google Scholar]
  13. Shear M. K., Maser J. D. Standardized assessment for panic disorder research. A conference report. Arch Gen Psychiatry. 1994 May;51(5):346–354. doi: 10.1001/archpsyc.1994.03950050006001. [DOI] [PubMed] [Google Scholar]
  14. Sheehan D. V., Zak J. P., Miller J. A., Jr, Fanous B. S. Panic disorder: the potential role of serotonin reuptake inhibitors. J Clin Psychiatry. 1988 Aug;49 (Suppl):30–36. [PubMed] [Google Scholar]
  15. Simpson R. J., Kazmierczak T., Power K. G., Sharp D. M. Controlled comparison of the characteristics of patients with panic disorder. Br J Gen Pract. 1994 Aug;44(385):352–356. [PMC free article] [PubMed] [Google Scholar]
  16. Zinbarg R. E., Barlow D. H., Brown T. A., Hertz R. M. Cognitive-behavioral approaches to the nature and treatment of anxiety disorders. Annu Rev Psychol. 1992;43:235–267. doi: 10.1146/annurev.ps.43.020192.001315. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES